ArticleDiseases (Basel, Switzerland)2026
Phase III Trial: Single Low-Dose 5 mg Dexamethasone with NEPA for Preventing 168 h Nausea and Vomiting of Diverse Highly or Moderately Emetogenic Chemotherapy (LD-NEPA).
Yuting He et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.